Scandinavian Biopharma and Neovii extend and expand their distribution agreement for the transplantation product Grafalon

Scandinavian Biopharma Distribution AB has extended and expanded its distribution agreement with Neovii Pharmaceuticals AG. This collaboration involves an extension of the agreement for the immunosuppressive drug Grafalon (anti-human T-lymphocyte immunoglobulin, ATLG) in Sweden, Norway, and Denmark, and now also includes Finland, thus encompassing all the Nordic countries. Grafalon is an antibody-based medication that is […]

Reckitt appoints Scandinavian Biopharma as the Distributor for the Nutramigen products in the Nordics

Reckitt has appointed Scandinavian Biopharma as the distributor for their Nutramigen products in the Nordic region. These products are classified as Food for Special Medical Purposes (FSMP) and are used by infants and toddlers with cow’s milk protein allergy. “Nutramigen is the latest addition to our innovative product portfolio in child health. We are incredibly […]

Join us! We are hiring a CMC Project Lead

We are looking for a senior project manager with experience and interest in leading complex pharmaceutical manufacturing and development projects from phase III to commercialization. We have an exciting journey ahead of us and we hope you want to join us on this journey! For more information about the role as CMC Project Lead click […]

Scandinavian Biopharma welcomes Christine Hägglund to the position as VP CMC Development

Scandinavian Biopharma is pleased to inform that Christine Hägglund has been recruited as Scandinavian Biopharmas VP CMC Development. Christine holds a PhD in Biochemistry and has almost 20 years of experience in drug development of biological pharmaceuticals. Most recently, she comes from the position of Director of Analytical Science & Technology at Sobi. “I really […]

The World Vaccine Congress is on!

The World Vaccine Congress is on – connecting people from all over the world to discuss innovative ideas in vaccine research! Our CEO, Björn Sjöstrand, and Program Director, Catharina Forzelius, are attending, excited to network amongst vaccinologists in Washington DC.



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.